The budget waltz ends on a slightly positive note, as the European Parliament lands an extra €100M for research. Horizon will now have €12.2B to spend next year
MEPs are set to vote through a new generation of public private partnerships under Horizon Europe. They want more transparency and less closed club mentality
Pharmaceutical strategy aims to boost EU drug discovery and prevent medicines shortages. Some MEPs want to go further and force companies to invest more of their profits in R&D and agree to flexible IP rules. Others say that is ‘tone deaf’
The revamped European Institute of Innovation and Technology will be more open, dynamic and better equipped to help innovators from all corners of Europe
During five years in office, Martin Schultz has turned the post of president into one of the most influential in the EU. With seven MEPs vying to replace him in the election Science|Business assesses their attitudes to R&D
Newly-elected EU Parliament President Antonio Tajani tells Science|Business where and how the EU should be spending its research cash in the coming years
Centre-left bloc in European Parliament reaches agreement over controversial investor protection provision in the proposed Transatlantic Trade and Investment Pact